# Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones

> **NCT01617551** · NA · UNKNOWN · sponsor: **Regional Hospital Holstebro** · enrollment: 30 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** NG-monomethyl-L-arginine (L-NMMA)

## Key facts

- **NCT ID:** NCT01617551
- **Lead sponsor:** Regional Hospital Holstebro
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01617551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01617551, "Effect of Renal Denervation on NO-mediated Sodium Excretion and Plasma Levels of Vasoactive Hormones". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01617551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*